87 related articles for article (PubMed ID: 10959160)
21. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
J Indian Med Assoc; 2008 Jul; 106(7):468-70, 480. PubMed ID: 18975506
[TBL] [Abstract][Full Text] [Related]
22. Diabetes prevention: still no effective drugs.
Prescrire Int; 2007 Dec; 16(92):258. PubMed ID: 18095391
[TBL] [Abstract][Full Text] [Related]
23. [When blood pressure control is a problem. Refractory hypertension is rare].
Offers E; Kolloch R
MMW Fortschr Med; 2002 Nov; 144(46):42-4, 46. PubMed ID: 12534081
[TBL] [Abstract][Full Text] [Related]
24. Acute pancreatitis due to ramipril therapy.
Kanbay M; Korkmaz M; Yilmaz U; Gur G; Boyacioglu S
Postgrad Med J; 2004 Oct; 80(948):617-8. PubMed ID: 15467001
[TBL] [Abstract][Full Text] [Related]
25. [Blood pressure limits for the initiation and goal of antihypertensive therapy. Blood pressure and cardiovascular risk].
Holzgreve H
MMW Fortschr Med; 2005 Jun; 147(23):37-8. PubMed ID: 15981903
[No Abstract] [Full Text] [Related]
26. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
[TBL] [Abstract][Full Text] [Related]
27. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
White WB; Cleveland JM; Rolleri RL;
J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
[TBL] [Abstract][Full Text] [Related]
28. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
29. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
30. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
32. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
[No Abstract] [Full Text] [Related]
33. Tolerability of 10 mg of ramipril in normotensive Indian patients.
Oomman A; Ramachandran P
Natl Med J India; 2002; 15(4):244. PubMed ID: 12296485
[No Abstract] [Full Text] [Related]
34. [Borderline values, antihypertensive drugs in comparison, additional measures. General practice tips for therapy of hypertension].
Kreutzberg K
MMW Fortschr Med; 2002 Jan; 144(3-4):12. PubMed ID: 11862785
[No Abstract] [Full Text] [Related]
35. [What should be considered with elderly hypertensive patients?].
Aumiller J
MMW Fortschr Med; 2009 Jun; 151(24):12-5. PubMed ID: 19645191
[No Abstract] [Full Text] [Related]
36. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
37. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
Ahmed N; Abdul Khaliq M; Shah SH; Anwar W
J Ayub Med Coll Abbottabad; 2008; 20(2):66-9. PubMed ID: 19385461
[TBL] [Abstract][Full Text] [Related]
38. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
Nilsson PM
Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
[No Abstract] [Full Text] [Related]
39. Lipid lowering: another method of reducing blood pressure?
Wierzbicki AS
J Hum Hypertens; 2002 Nov; 16(11):753-60. PubMed ID: 12444536
[TBL] [Abstract][Full Text] [Related]
40. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
